Search
Powered By HealthLine
Health Tools
 Coughing Causes
 Allergy Medicine & Treatment
 Chronic Obstructive Pulmonary Disease
 Living With Asthma
 Respiratory Illnesses
Featured Conditions
 Allergy
 Asthma
 Cold & Flu
 Stop Smoking
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Toprol XL

[Metoprolol]

Using the E max model, the maximal beta 1 -blocking effect has been estimated to produce a 30% reduction in exercise heart rate. Beta 1 -blocking effects in the range of 30Ð 80% of the maximal effect (corre-sponding to approximately 8Ð 23% reduction in exercise heart rate) are expected to occur at metoprolol plasma concentrations ranging from 30Ð 540 nmol/ L. The concen-tration-effect curve begins reaching a plateau between 200Ð 300 nmol/ L, and higher plasma levels produce little additional beta 1 -blocking effect. The relative beta 1 -selec-tivity of metoprolol diminishes and blockade of beta 2 -adrenoceptors increases at higher plasma concentrations.

Although beta-adrenergic receptor blockade is useful in the treatment of angina, hyper-tension, and heart failure there are situations in which sympathetic stimulation is vital. In patients with severely damaged hearts, adequate ventricular function may depend on sympathetic drive. In the presence of AV block, beta-blockade may prevent the neces-sary facilitating effect of sympathetic activity on conduction. Beta 2 -adrenergic blockade results in passive bronchial constriction by interfering with endogenous adrenergic bronchodilator activity in patients subject to bronchospasm and may also interfere with exogenous bronchodilators in such patients.

In other studies, treatment with TOPROL-XL produced an improvement in left ventric-ular ejection fraction. TOPROL-XL was also shown to delay the increase in left ventricular end-systolic and end-diastolic volumes after 6 months of treatment.

Text Continues Below



Hypertension

The mechanism of the antihypertensive effects of beta-blocking agents has not been elucidated. However, several possible mechanisms have been proposed: (1) competi-tive antagonism of catecholamines at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output; (2) a central effect leading to reduced sympathetic outflow to the periphery; and (3) suppression of renin activity.

Page:  << Prev | 1 | 2 | 3 | 4 | 5 | Next >>







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2012. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire